Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Hybridon, Inc. (OTC BB:HYBN.OB)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | SEC | Financials
Location
345 Vassar Street
Cambridge, MA 02139
Phone: (617) 679-5500
Fax: (617) 679-5592
Email: m.knight@noonanrusso.com
Employees (last reported count): 14
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 51%
·Institutional: 0% (0% of float)
(one institution)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Hybridon, Inc. utilizes chemically modified synthetic DNA for medical applications, including the discovery and development of genetically based drugs, which treat diseases by acting on a particular gene. The genetic drugs being developed by Hybridon are based on "antisense" technology, in that they use synthetic DNA material, also called oligonucleotides, with the aim of inhibiting or reducing the body's production of proteins that directly or indirectly cause or support a given disease. Hybridon has also developed a portfolio of chemically modified DNA compounds designed to stimulate responses of the immune system. Hybridon has developed and owns certain medicinal chemistry innovations useful in the design of new synthetic DNA compounds. Hybridon also has rights to technology allowing the chemical modification of synthetic DNA.
More from Market Guide: Expanded Business Description

Financial Summary
Hybridon is engaged in the discovery and development of novel genetic medicines based primarily on antisense technology. For the six months ended 6/30/01, revenues totalled $552 thousand, up from $153 thousand. Net loss from continuing operations applicable to Common before extraordinary item fell 76% to $1.6 million. Revenues reflect collaboration and license agreements Isis and EpiGenesis. Lower loss reflects a $6.9 million gain on the sale of Methylgene, Inc. shares.
More from Market Guide: Significant Developments

Officers
FY2000 Pay

James Wyngaarden, M.D., 76
Chairman
--  
Stephen Seiler, 45
CEO, Director
--  
Sudhir Agrawal, 47
Pres, CSO
$381K
Youssef El-Zein, 52
Vice Chairman
--  
Robert Andersen, 50
CFO, VP-Operations and Planning,Treasurer, Assistant Sec.
245K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- OTC BB:HYBN.OBAs of 31-Aug-2001
Price and Volume
52-Week Low
on 20-Dec-2000
$0.281
Recent Price$1.10 
52-Week High
on 29-May-2001
$1.51 
Beta-0.07 
Daily Volume (3-month avg)51.7K
Daily Volume (10-day avg)54.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+35.3%
52-Week Change
relative to S&P500
+81.5%
Share-Related Items
Market Capitalization$21.2M
Shares Outstanding19.3M
Float9.40M
Dividends & Splits
Annual Dividendnone 
Last Split: 1 for 5 on 11-Dec-1997
Per-Share Data
Book Value (mrq)$0.09 
Earnings (ttm)-$0.46 
Earnings (mrq)$0.06 
Sales (ttm)$0.04 
Cash (mrq)$0.97 
Valuation Ratios
Price/Book (mrq)11.99 
Price/EarningsN/A 
Price/Sales (ttm)31.64 
Income Statements
Sales (ttm)$972.0K
EBITDA (ttm)-$7.38M
Income available to common (ttm)-$7.44M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-27.61%
Return on EquityN/A 
Financial Strength
Current Ratio (mrq)3.16 
Debt/Equity (mrq)2.84 
Total Cash (mrq)$18.7M
Short Interest
As of 10-Nov-1997
Shares Short61.0K
Percent of Float3.4%
Shares Short
(Prior Month)
61.0K
Short Ratio6.78 
Daily Volume9,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.